Vioptix INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$90Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
324clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $20K
2020 $4,502
2021 $13K
2022 $7,210
2023 $3,512
2024 $4,749
2025 $38K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Plastic and Reconstructive Surgery $41K
Surgery $17K
Plastic Surgery $15K
Colon & Rectal Surgery $7,976
Interventional Cardiology $6,000
Otolaryngology $899

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Mitchell Pet Saint Louis, MO Plastic and Reconstructive Surgery $33,675.78
Danny Sherwinter Brooklyn, NY Surgery $12,627.25
Rajendra Patel New York, NY Interventional Cardiology $6,000.00
Ergun Kocak Gahanna, OH Plastic Surgery $2,649.99
Phillip Fleshner West Hollywood, CA Colon & Rectal Surgery $2,526.00
Pankaj Tiwari Gahanna, OH Plastic Surgery $2,044.84
Peter Koltz Toledo, OH Plastic Surgery $1,660.46
Elisabeth Potter Austin, TX Plastic and Reconstructive Surgery $1,353.49
Darrin Hubert Richmond, VA Plastic Surgery $718.60
Bernard Lee Boston, MA Plastic Surgery $639.80

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.